Clinical impact of febrile neutropenia (FIN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer

被引：0
|
作者：
Hamilton, Erika Paige
Topping, Donna L.
Peppercorn, Jeffrey M.
Marcom, P. Kelly
Kimmick, Gretchen Genevieve
Duff, Erin
Cirrincione, Constance T.
Blackwell, Kimberly L.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Duke Canc Inst Biostat, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1076
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
    Sohn, Byeong Seok
    Jeong, Jae Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Jeong Eun
    Sohn, Joo Hyuk
    Koh, Su-Jin
    Seo, Jae Hong
    Lee, Keun Seok
    Kim, Sung-Bae
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 866 - 873
  • [42] PROPHYLAXIS OF NEUTROPENIA DURING ADJUVANT DAC (DOCETAXEL, DOXORUBICIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY WITH DICARBAMIN IN PATIENTS WITH EARLY BREAST CANCER
    Kopp, M. V.
    Koroleva, I. A.
    Shaplygin, L. V.
    Machalova, A. S.
    ANNALS OF ONCOLOGY, 2012, 23 : 521 - 522
  • [43] BUDGET IMPACT ON THE USE OF PEGFILGRASTIM TO REDUCE THE FEBRILE NEUTROPENIA DURING CHEMOTHERAPY FOR BREAST CANCER WITH MODERATE RISK COMPARED TO A STANDARD THERAPY
    Choi, W. S.
    Lee, Y. J.
    Ju, S. Y.
    Heo, S. B.
    Kim, C. M.
    VALUE IN HEALTH, 2014, 17 (07) : A623 - A623
  • [44] Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice
    Lyman, Gary H.
    Richert-Boe, Kathryn
    Lamerato, Lois
    Kaur, Manpreet
    Shah, Neel
    Lawrence, Tatiana
    Sundaresan, Devi
    Silvia, Amanda
    Hanau, Ahuva
    Weycker, Derek
    BLOOD, 2019, 134
  • [45] COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim
    Gwak, Hongki
    Lim, Seung-Taek
    Jeon, Ye-Won
    Park, Hyung Soon
    Kim, Seong Hwan
    Suh, Young-Jin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [46] Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)
    Mark Clemons
    Sasha Mazzarello
    John Hilton
    Anil Joy
    Julie Price-Hiller
    Xiaofu Zhu
    Shailendra Verma
    Anne Kehoe
    Mohammed FK Ibrahim
    Marta Sienkiewicz
    Carol Stober
    Lisa Vandermeer
    Brian Hutton
    Ranjeeta Mallick
    Dean Fergusson
    Supportive Care in Cancer, 2019, 27 : 1345 - 1354
  • [47] Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)
    Clemons, Mark
    Mazzarello, Sasha
    Hilton, John
    Joy, Anil
    Price-Hiller, Julie
    Zhu, Xiaofu
    Verma, Shailendra
    Kehoe, Anne
    Ibrahim, Mohammed F. K.
    Sienkiewicz, Marta
    Stober, Carol
    Vandermeer, Lisa
    Hutton, Brian
    Mallick, Ranjeeta
    Fergusson, Dean
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1345 - 1354
  • [48] The real-world experience of adjuvant docetaxel and cyclophosphamide (TC) chemotherapy in HER-2 negative breast cancer.
    Mata, Danilo Giffoni M. M.
    Chan, Kelvin K.
    Eisen, Andrea
    Pezo, Rossanna C.
    Menjak, Ines B.
    Trudeau, Maureen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis
    Li, Edward
    Schroader, Bridgette Kanz
    Campbell, David
    Campbell, Kim
    Wang, Weijia
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 106 - 115
  • [50] Efficacy of scalp cryotherapy in preventing alopecia among patients with breast cancer patients receiving adjuvant docetaxel and cyclophosphamide
    Cigler, Tessa
    Fiederlein, Barbara
    Schneider, Sarah E.
    Chuang, Ellen
    Vandat, Linda T.
    Donovan, Diana
    Welch, Roberto
    Cobham, Marta E.
    Moore, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345